Indomethacin for renal impairment in neonatal Bartter's syndrome: Letter to the Editor

Jonathan C. Craig, Michael C. Falk

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)

Abstract

Sir - Bartter’s syndrome causes muscle weakness, polyuria, polydipsia, failure to thrive, delayed growth, hypokalaemia, metabolic alkalosis, hyper-reninaemia, hyperaldosteronism, increased urinary prostaglandin excretion, and renal impairment. Polyhydramnios with hypercalciuria and nephrocalcinosis are features of the neonatal form of the condition. Indomethacin promotes catch-up growth and reverses nephrocalcinosis. We report the effect of indomethacin on glomerular function in a 5-year-old girl with Bartter’s syndrome.
Original languageEnglish
Pages (from-to)550
JournalLancet
Volume347
Issue number9000
DOIs
Publication statusPublished - 24 Feb 1996
Externally publishedYes

Keywords

  • Bartter's syndrome
  • children
  • indomethacin

Fingerprint

Dive into the research topics of 'Indomethacin for renal impairment in neonatal Bartter's syndrome: Letter to the Editor'. Together they form a unique fingerprint.

Cite this